Vimarsana
Biggest News Aggregation in the World

Simron Singh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simron Singh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simron Singh Today - Breaking & Trending Today

Family Doctors' Burnout Is about More than Their Workload - Vimarsana News

Family Doctors' Burnout Is about More than Their Workload

Many physicians believe there needs to be a reset in how they treat patients—and their own well-being

Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compared to Comparator in Patients With Advanced GEP-NETs - Vimarsana News

Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compared to Comparator in Patients With Advanced GEP-NETs

Radioligands may be able to deliver radiation to advanced tumor cells anywhere in the body.

Data Support Upfront Radioligand Therapy in High-Grade NETs - Vimarsana News

Data Support Upfront Radioligand Therapy in High-Grade NETs

Some physicians commented, however, that they will reserve 177Lu-DOTATATE in the first line for the most aggressive cases.

Radioligand Gets Big Win in High-Grade GEP Neuroendocrine Tumors - Vimarsana News

Radioligand Gets Big Win in High-Grade GEP Neuroendocrine Tumors

Lutetium dotatate reduces PFS risk by 72% in randomized trial

177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs - Vimarsana News

177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs

Lutetium Lu 177 dotatate plus octreotide significantly improved PFS vs high-dose octreotide in patients with gastroenteropancreatic neuroendocrine tumors.